Medicare Enrolled

Dr. Andres Giron, M.D.

Pulmonary Disease · Thousand Oaks, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
555 MARIN ST, Thousand Oaks, CA 91360
8054960440
In practice since 2006 (19 years)
NPI: 1922027630 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Giron from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Giron? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Giron

Dr. Andres Giron is a pulmonary disease specialist in Thousand Oaks, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Giron performed 3,369 Medicare services across 2,035 unique beneficiaries.

Between the years covered by Open Payments, Dr. Giron received a total of $10,352 from 28 pharmaceutical and/or device companies across 536 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Giron is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 10% volume in CA $10,352 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,369
Medicare services
Top 10% in CA for pulmonary disease
2,035
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~177 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
1,268 $148 $260
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
575 $98 $300
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
370 $98 $196
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
277 $42 $95
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
183 $8 $20
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
165 $7 $30
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
94 $10 $30
New patient office visit, complex (60-74 min) 93 $178 $321
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
76 $24 $60
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
76 $142 $504
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
73 $10 $30
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
68 $8 $30
Sleep study with heart rate and breathing monitoring
A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function.
38 $33 $220
Exercise-induced bronchospasm test
A test used to check for exercise-induced bronchospasm, which is a narrowing of the lung airways triggered by physical activity.
13 $78 $145
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,352
Total received (2018-2024)
Avg $1,479/year across 7 years
Top 16% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
536
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,221 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$131 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,317
2023
$2,227
2022
$1,363
2021
$1,388
2020
$906
2019
$1,028
2018
$1,123

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mylan Specialty L.P.
$406
GlaxoSmithKline, LLC.
$314
Boehringer Ingelheim Pharmaceuticals, Inc.
$288
GENZYME CORPORATION
$271
AstraZeneca Pharmaceuticals LP
$268
Insmed, Inc.
$166
Electromed, Inc.
$163
Regeneron Healthcare Solutions, Inc.
$114
INOGEN, INC.
$109
Amgen Inc.
$79
Azurity Pharmaceuticals, Inc.
$57
Pulmonx Corporation
$40
IDORSIA PHARMACEUTICALS US INC
$24
Merck Sharp & Dohme LLC
$19
Top 3 companies account for 43.5% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,397
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,090
AstraZeneca Pharmaceuticals LP
$1,839
Mylan Specialty L.P.
$982
GENZYME CORPORATION
$703
Regeneron Healthcare Solutions, Inc.
$499
Electromed, Inc.
$292
Insmed, Inc.
$289
Pulmonx Corporation
$154
Janssen Pharmaceuticals, Inc
$110
INOGEN, INC.
$109
Amgen Inc.
$94
IDORSIA PHARMACEUTICALS US INC
$87
SANOFI-AVENTIS U.S. LLC
$80
Genentech USA, Inc.
$67
Circassia Pharmaceuticals Inc
$66
E.R. Squibb & Sons, L.L.C.
$62
Grifols USA, LLC
$58
Azurity Pharmaceuticals, Inc.
$57
United Therapeutics Corporation
$47
Sunovion Pharmaceuticals Inc.
$46
Merck Sharp & Dohme LLC
$45
Merck Sharp & Dohme Corporation
$42
Baxter Healthcare
$42
Actelion Pharmaceuticals US, Inc.
$30
Medtronic Vascular, Inc.
$24
Olympus America Inc.
$22
Inogen, Inc.
$19
Top 3 companies account for 61.1% of all-time payments
Associated products mentioned in payments ›
3F · AIRSUPRA · ANORO · ANORO ELLIPTA · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · Esbriet · FARXIGA · FASENRA · HORIZANT · Hillrom - Life 2000 Ventilation System · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · InogenOne · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT MACITENTAN · Olympus Respiratory Accessories · Prolastin-C Liquid · QUVIVIQ · Repatha · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UTIBRON · WINREVAIR · XARELTO · Xolair · YUPELRI · Yupelri · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Thousand Oaks?
Compare pulmonary diseases in the Thousand Oaks area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
41
Per 100K population
4.9
County median income
$107,327
Nearest hospital
LOS ROBLES HOSPITAL & MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Giron is a clinical cardiology specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Giron experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Giron performed 1,268 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Giron receive payments from pharmaceutical companies?
Yes. Dr. Giron received a total of $10,352 from 28 companies across 536 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Giron's costs compare to other pulmonary diseases in Thousand Oaks?
Dr. Giron's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Giron) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →